Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Ingredion
INGR
$6.62B
| $7.18M | 0.01% |
78,513
-105,523
| -57% | -$10.6M |
|
1327
Option Care Health
OPCH
$3.54B
| $7.17M | 0.01% |
502,181
-66,427
| -12% | -$876K |
|
1328
Shopify
SHOP
$198B
| $7.16M | 0.01% |
+517,380
| New | +$7.28M |
|
1329
Knowles
KN
$2.87B
| $7.16M | 0.01% |
537,724
+516,141
| +2,391% | +$7.56M |
|
1330
Fossil Group
FOSL
$323M
| $7.15M | 0.01% |
454,770
+383,098
| +535% | +$7.42M |
|
1331
Paylocity
PCTY
$8.08B
| $7.15M | 0.01% |
118,788
-78,273
| -40% | -$5.02M |
|
|
TDAY
1332
USA Today Co
TDAY
$953M
| $7.15M | 0.01% |
617,911
+387,609
| +168% | +$5.41M |
|
1333
Standard Motor Products
SMP
$838M
| $7.15M | 0.01% |
147,596
+126,604
| +603% | +$6.3M |
|
|
INN
1334
Summit Hotel Properties
INN
$669M
| $7.12M | 0.01% |
731,211
-289,550
| -28% | -$3.28M |
|
1335
Diodes
DIOD
$4.28B
| $7.1M | 0.01% |
220,055
-28,732
| -12% | -$918K |
|
|
GDEN
1336
DELISTED
Golden Entertainment
GDEN
| $7.07M | 0.01% |
441,394
-231,686
| -34% | -$4.22M |
|
1337
LyondellBasell Industries
LYB
$20.2B
| $7.03M | 0.01% |
84,552
-767,585
| -90% | -$70.2M |
|
|
AKRX
1338
DELISTED
Akorn Inc
AKRX
| $7.01M | 0.01% |
2,068,124
+1,292,897
| +167% | +$7.69M |
|
1339
Itaú Unibanco
ITUB
$84.4B
| $7M | 0.01% |
+1,053,229
| New | +$6.77M |
|
|
HPP
1340
Hudson Pacific Properties
HPP
$809M
| $7M | 0.01% |
34,429
-34,845
| -50% | -$7.45M |
|
|
BPYU
1341
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $7M | 0.01% |
434,740
-283,030
| -39% | -$5.17M |
|
1342
Pampa Energía
PAM
$4.28B
| $6.98M | 0.01% |
219,307
+135,336
| +161% | +$4.39M |
|
1343
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.55B
| $6.97M | 0.01% |
318,000
-236,217
| -43% | -$5.5M |
|
|
SNBR
1344
DELISTED
Sleep Number
SNBR
| $6.96M | 0.01% |
219,397
+170,352
| +347% | +$6.05M |
|
|
VXX
1345
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
| $6.92M | 0.01% |
147,671
-211,604
| -59% | -$7.83M |
|
1346
Adeia
ADEA
$2.99B
| $6.92M | 0.01% |
1,422,535
+779,992
| +121% | +$3.04M |
|
1347
CONMED
CNMD
$1.53B
| $6.92M | 0.01% |
107,796
+94,212
| +694% | +$6.45M |
|
1348
Saia
SAIA
$9.17B
| $6.92M | 0.01% |
123,943
-74,375
| -38% | -$4.52M |
|
1349
Newmark Group
NMRK
$2.9B
| $6.92M | 0.01% |
862,182
+229,017
| +36% | +$2.17M |
|
1350
Ultrapar
UGP
$7.14B
| $6.88M | 0.01% |
1,016,394
+48,196
| +5% | +$280K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.